Michael Hemann seeks better ways to deploy chemotherapy drugs and overcome tumor resistance.
Through the first quarter of 1997, the MIT Retirement Plan's Variable Fund experienced a loss of 0.48 percent. The Standard & Poor's 500 Index advanced 2.7 percent during the same period. Fixed Fund member accounts have been credited with distributions of 2.33 percent for the first three months of 1997.
A version of this article appeared in MIT Tech Talk on May 14, 1997.